Cleared Traditional

K922335 - BARTELS RUBEOLA IGM EIA

K922335 is an FDA 510(k) clearance for BARTELS RUBEOLA IGM EIA, manufactured by Baxter Diagnostics, Inc.. The device is a Class 1 Microbiology device with product code LJB cleared through the Traditional 510(k) pathway after a 112-day FDA review.

K922335 · Baxter Diagnostics, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1992
Decision
112d
Days
Class 1
Risk

K922335 is an FDA 510(k) clearance for the BARTELS RUBEOLA IGM EIA. Classified as Enzyme Linked Immunoabsorbent Assay, Rubeola Igg (product code LJB), Class I - General Controls.

Submitted by Baxter Diagnostics, Inc. (Bellevue, US). The FDA issued a Cleared decision on September 2, 1992 after a review of 112 days - within the typical 510(k) review window.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3520 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Baxter Diagnostics, Inc. devices

FDA 510(k) Submission Details - K922335

510(k) Number K922335 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 13, 1992
Decision Date September 02, 1992
Days to Decision 112 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
10d slower than avg
Panel avg: 102d · This submission: 112d
Pathway characteristics
Predicate-based equivalence.

LJB Device Classification - Class 1, General Controls

Product Code LJB Enzyme Linked Immunoabsorbent Assay, Rubeola Igg
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3520
Definition The Qualitative Detection Of Measles Specific Igg Antibodies In Serum Or Plasma.
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - LJB Enzyme Linked Immunoabsorbent Assay, Rubeola Igg

All 8
Devices cleared under the same product code (LJB) and FDA review panel - the closest regulatory comparables to K922335.
DIAMEDIX IS-MEASLES IGG TEST SYSTEM
K974552 · Diamedix Corp. · Jan 1998
QUANTA LITE RUBEOLA (MEASLES) IGG
K971620 · Inova Diagnostics, Inc. · Jul 1997
BARTELS RUBEOLA IGG EIA
K922330 · Baxter Diagnostics, Inc. · Sep 1992
RUBEOLA IGM ELISA TEST
K904083 · Gull Laboratories, Inc. · Jan 1991
MEASLES IGG MICROASSAY
K903961 · Diamedix Corp. · Dec 1990
RUBEOLA IGG ELISA TEST
K904854 · Gull Laboratories, Inc. · Dec 1990